Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Gabapentin may cause hair loss in patients treated for neuropathic pain.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Sudden weight loss can cause significant hair loss, and using colchicine on the skin for psoriasis may be unsafe.

PRP is an effective and safe treatment for female hair loss.

Most adult women experiencing hair loss are aged 21-40, with the most common type being female pattern hair loss. Trichoscopy is a useful tool for diagnosing different types of hair loss.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Most orthodontic patients with missing teeth also have hair disorders.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

A supplement with Serenoa repens improved hair loss in a patient.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

People with HIV and low T cell counts have more hair and scalp problems.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

The trichotillometer is a simple, effective tool for diagnosing and assessing female pattern hair loss.